Dr. Kenneth L. Buch, MD

Dr. Buch practices at Pacific Ritz Surgery Center in Encino, California.

Dr. Buch's NPI, 1346200730, was assigned on March 28, 2006. Dr. Buch graduated from Weill Cornell Medicine in 1978. Dr. Buch holds California license G44883.

Dr. Buch's primary practice is Pacific Ritz Surgery Center, at 16311 Ventura Blvd, Suite 570, Encino, CA 91436. The practice phone is (818) 827-5100.

Dr. Buch's primary practice is Pacific Ritz Surgery Center in Encino, California. Dr. Buch is also affiliated with Providence Cedars-Sinai Tarzana Medical Center. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Buch to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buch practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Buch's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Buch is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Buch's licenses on file in 2 states: California and New York.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Buch treats.

CMS data shows 2,457 Medicare services from Dr. Buch across 15 procedure codes in 2024, for 659 Medicare patients. Medicare paid $185,198 for them.

CMS counts 659 Medicare patients who saw Dr. Buch in 2024. The largest group is 65 to 74, with 327 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buch's median patient age at 60, with 48% women.

In 2024, Dr. Buch wrote 884 Medicare Part D claims for 255 patients. 74% of them were for generic drugs. CMS names the drug for 742 of them, across 20 drugs with 11 or more claims each, at $380,590 in total drug cost. In 2023, CMS named 825 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Buch for performance year 2024, reported as part of a group. Dr. Buch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buch as offering telehealth. CMS counts 164 procedures of colonoscopy by Dr. Buch, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Buch. The most frequent topics are Duodenogastric Reflux, Gastritis and Peptic Ulcer.

Dmand AI links Dr. Buch to 1 clinical trial. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases. Open Payments lists research payments to Dr. Buch that name 1 trial.

CMS Open Payments shows 521 general payments to Dr. Buch from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,660. It also lists 6 research payments totaling $8,800 from 2016 to 2021, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Buch, most recently CMS Stage 1 EHR in 2013.

Dr. Buch graduated from Weill Cornell Medicine in 1978.

Dr. Buch is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.